111 related articles for article (PubMed ID: 12027197)
21. Clinical significance of MUC1 and E-cadherin expression, cellular proliferation, and angiogenesis at the deepest invasive portion of colorectal cancer.
Kimura T; Tanaka S; Haruma K; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Int J Oncol; 2000 Jan; 16(1):55-64. PubMed ID: 10601549
[TBL] [Abstract][Full Text] [Related]
22. Patients with CD133-negative colorectal liver metastasis have a poor prognosis after hepatectomy.
Yamamoto S; Tanaka K; Takeda K; Akiyama H; Ichikawa Y; Nagashima Y; Endo I
Ann Surg Oncol; 2014 Jun; 21(6):1853-61. PubMed ID: 24554065
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in squamous cell carcinoma of the esophagus.
Koide N; Watanabe H; Yazawa K; Adachi W; Amano J
Hepatogastroenterology; 1999; 46(26):944-51. PubMed ID: 10370644
[TBL] [Abstract][Full Text] [Related]
24. Preoperative treatment with tegafur suppositories enhances apoptosis and reduces the intratumoral microvessel density of human colorectal carcinoma.
Matsuura T; Fukuda Y; Fujitaka T; Nishisaka T; Sakatani T; Ito H
Cancer; 2000 Mar; 88(5):1007-15. PubMed ID: 10699888
[TBL] [Abstract][Full Text] [Related]
25. Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma.
Tanaka S; Haruma K; Tatsuta S; Hiraga Y; Teixeira CR; Shimamoto F; Yoshihara M; Sumii K; Kajiyama G
Oncology; 1995; 52(2):134-9. PubMed ID: 7854773
[TBL] [Abstract][Full Text] [Related]
26. [Hepatic lymph node involvement in patients with synchronous multiple liver metastases of colorectal cancer].
Ishibashi K; Ohsawa T; Yokoyama M; Ishizuka N; Miyazaki T; Nakada H; Gonda T; Ishida H
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1834-7. PubMed ID: 17212121
[TBL] [Abstract][Full Text] [Related]
27. Morphological aspects of the hepatic response to neoadjuvant therapy.
Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
[TBL] [Abstract][Full Text] [Related]
28. Venous invasion and down-regulation of p21(WAF1/CIP1) are associated with metastasis in colorectal carcinomas.
Mitomi H; Mori A; Kanazawa H; Nishiyama Y; Ihara A; Otani Y; Sada M; Kobayashi K; Igarashi M
Hepatogastroenterology; 2005; 52(65):1421-6. PubMed ID: 16201087
[TBL] [Abstract][Full Text] [Related]
29. CD10 expression in colorectal carcinoma correlates with liver metastasis.
Fujimoto Y; Nakanishi Y; Sekine S; Yoshimura K; Akasu T; Moriya Y; Shimoda T
Dis Colon Rectum; 2005 Oct; 48(10):1883-9. PubMed ID: 16175325
[TBL] [Abstract][Full Text] [Related]
30. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
[TBL] [Abstract][Full Text] [Related]
31. [Immunohistochemical study of thymidine phosphorylase in uterine cervical intraepithelial neoplasia].
Kaneoka A; Obata T; Takasu K
Rinsho Byori; 1997 May; 45(5):483-6. PubMed ID: 9170977
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the proliferative activity of superficial esophageal carcinoma using MIB-1 immunostaining for the Ki-67 antigen.
Chino O; Makuuchi H; Shimada H; Machimura T; Mitomi T; Osamura RY
J Surg Oncol; 1998 Jan; 67(1):18-24. PubMed ID: 9457251
[TBL] [Abstract][Full Text] [Related]
33. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
[TBL] [Abstract][Full Text] [Related]
34. Cell proliferation, apoptosis and angiogenesis in gastric cancer and its hepatic metastases.
Koide N; Nishio A; Hiraguri M; Shimada K; Shimozawa N; Hanazaki K; Kajikawa S; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(45):869-73. PubMed ID: 12064010
[TBL] [Abstract][Full Text] [Related]
35. Ki-67 antibody labeling index in colorectal carcinoma.
Suzuki H; Matsumoto K; Terabe M
J Clin Gastroenterol; 1992 Dec; 15(4):317-20. PubMed ID: 1294637
[TBL] [Abstract][Full Text] [Related]
36. Proliferative, infiltrative, and metastatic activities in colorectal tumors assessed by MIB-1 antibody.
Ishida H; Sadahiro S; Suzuki T; Ishikawa K; Kamijo A; Tajima T; Makuuchi H; Murayama C
Oncol Rep; 2003; 10(6):1741-5. PubMed ID: 14534689
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling.
Tatebe S; Ishida M; Kasagi N; Tsujitani S; Kaibara N; Ito H
Int J Cancer; 1996 Jan; 65(2):173-7. PubMed ID: 8567113
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma.
Murakami M; Sasaki T; Kuwada Y; Yamasaki S; Kuwahara K; Chayama K
Oncol Rep; 2003; 10(5):1091-6. PubMed ID: 12883663
[TBL] [Abstract][Full Text] [Related]
39. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas.
Choi HJ; Jung IK; Kim SS; Hong SH
Dis Colon Rectum; 1997 Jan; 40(1):51-9. PubMed ID: 9102262
[TBL] [Abstract][Full Text] [Related]
40. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases.
Petrowsky H; Sturm I; Graubitz O; Kooby DA; Staib-Sebler E; Gog C; Köhne CH; Hillebrand T; Daniel PT; Fong Y; Lorenz M
Eur J Surg Oncol; 2001 Feb; 27(1):80-7. PubMed ID: 11237496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
